Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
156.4 USD | +1.86% | +19.84% | -13.00% |
Apr. 23 | Sector Update: Health Care Stocks Rise in Afternoon Trading | MT |
Apr. 23 | BeiGene Says Tislelizumab Gets European Commission's Approval to Treat Non-Small Cell Lung Cancer; Shares Rise | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-13.00% | 16.05B | |
-2.70% | 103B | |
+1.69% | 95.28B | |
+1.46% | 22.15B | |
-15.97% | 21.02B | |
-8.58% | 18.15B | |
-38.74% | 16.73B | |
+4.59% | 13.68B | |
+35.27% | 12.17B | |
-23.32% | 8.24B |
- Stock Market
- Equities
- BGNE Stock
- News BeiGene, Ltd.
- Nomura Adjusts BeiGene Price Target to $268.36 From $253.14, Maintains Buy Rating